Johnson & Johnson

JNJ

$160.50

+11.33% (1 year change)

Avg closing price

Price range

Market Cap

$427 Billion

The market capitalization is the market value of the company. It is the sum of the value of all outstanding shares.

Revenue

$21.1 Billion

Total revenue in the last quarter.

Net Income

$3.55 Billion

Net income is all revenues minus all expenses including taxes and interest in the last quarter.

Earnings per Share

$5.51

Earnings per share is the amount of net income that is attributed to each single share outstanding.

Dividends per Share

$4.00 (2.47%)

Dividends per share is the amount of dividends paid out to the shareholder of a single share in the last 12 months. The percentage indicates the ratio of the company's annual dividend compared to its current price per share (stock price).

Price-Earnings Ratio

29.03x

The price-earnings ratio is the ratio between the price per share (stock price) and the earnings per share. It indicates the percentage of the price per share (stock price) that is generated in earnings in the last 12 months.

EBIT

$5.84 Billion

Earnings before interest expenses and taxes in the last quarter.

Employees

0

The number of full time employees.

Revenue & Earnings

Balance Sheet

Johnson & Johnson

At Johnson & Johnson, we believe good health is the foundation of vibrant lives, thriving communities and forward progress. That’s why for more than 130 years, we have aimed to keep people well at every age and every stage of life. Today, as the world’s largest and most broadly-based healthcare company, we are committed to using our reach and size for good. We strive to improve access and affordability, create healthier communities, and put a healthy mind, body and environment within reach of everyone, everywhere. We are blending our heart, science and ingenuity to profoundly change the trajectory of health for humanity.

News

Earnings Scheduled For April 20, 2021

Earnings Scheduled For April 20, 2021

Companies Reporting Before The Bell • GATX (NYSE: GATX ) is projected to report quarterly earnings at $0.85 per share on revenue of $303.17 million. • Simmons First National (NASDAQ: SFNC ) is like...

Benzinga Benzinga, 1 day ago
Fear that Johnson & Johnson pause could heighten vaccine hesitancy in US

Fear that Johnson & Johnson pause could heighten vaccine hesitancy in US

A deflating pattern is emerging in rural, conservative and vaccine-hesitant states as authorities worry that stakes could not be higher in those same communities Teton county, Wyoming, is at the va...

The Guardian The Guardian, 2 days ago
Trump takes jab at ‘lunacy’ of Johnson & Johnson vaccination pause

Trump takes jab at ‘lunacy’ of Johnson & Johnson vaccination pause

Former President Donald Trump took aim at the Biden administration on Friday evening for allowing for a pause in the Johnson & Johnson coronavirus vaccine, accusing them of allowing “insanely risk-...

New York Post New York Post, 4 days ago